[1]
Aakeröy, C.B.; Forbes, S.; Desper, J. Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. J. Am. Chem. Soc., 2009, 131(47), 17048-17049.
[2]
Blagden, N.; de Matas, M.; Gavan, P.T.; York, P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv. Drug Deliv. Rev., 2007, 59(7), 617-630.
[3]
Rasenack, N.; Steckel, H.; Müller, B.W. Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. J. Pharm. Sci., 2003, 92(1), 35-44.
[4]
Umeda, Y.; Fukami, T.; Furuishi, T.; Suzuki, T.; Tanjoh, K.; Tomono, K. Characterization of multicomponent crystal formed between indomethacin and lidocaine. Drug Dev. Ind. Pharm., 2009, 35(7), 843-851.
[5]
Torchilin, V.P. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J., 2007, 9(2), E128-E147.
[6]
Ervasti, T.; Aaltonen, J.; Ketolainen, J. Theophylline-nicotinamide cocrystal formation in physical mixture during storage. Int. J. Pharm., 2015, 486(1-2), 121-130.
[7]
Rahman, Z.; Samy, R.; Sayeed, V.A.; Khan, M.A. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin. Pharm. Dev. Technol., 2012, 17(4), 457-465.
[8]
Hiendrawan, S.; Veriansyah, B.; Widjojokusumo, E.; Soewandhi, S.N.; Wikarsa, S.; Tjandrawinata, R.R. Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid. Int. J. Pharm., 2016, 497(1-2), 106-113.
[9]
Suzuki, N.; Kawahata, M.; Yamaguchi, K.; Suzuki, T.; Tomono, K.; Fukami, T. Comparison of the relative stability of pharmaceutical cocrystals consisting of paracetamol and dicarboxylic acids. Drug Dev. Ind. Pharm., 2018, 44(4), 582-589.
[10]
Ullah, M.; Hussain, I.; Sun, C.C. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev. Ind. Pharm., 2016, 42(6), 969-976.
[11]
Sarkar, A.; Rohani, S. Cocrystals of acyclovir with promising physico-chemical properties. J. Pharm. Sci., 2015, 104(1), 98-105.
[12]
Nechipadappu, S.K.; Tekuri, V.; Trivedi, D.R. Pharmaceutical co-crystal of flufenamic acid: synthesis and characterization of two novel drug-drug co-crystal. J. Pharm. Sci., 2017, 106(5), 1384-1390.
[13]
Bhatt, P.M.; Azim, Y.; Thakur, T.S.; Desiraju, G.R. Co-crystals of the anti-hiv drugs lamivudine and zidovudine. Cryst. Growth Des., 2009, 9(2), 951-957.
[14]
Malamatari, M.; Ross, S.A.; Douroumis, D.; Velaga, S.P. Experimental cocrystal screening and solution based scale-up cocrystallization methods. Adv. Drug Deliv. Rev., 2017, 117, 162-177.
[15]
Healy, A.M.; Worku, Z.A.; Kumar, D.; Madi, A.M. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals. Adv. Drug Deliv. Rev., 2017, 117, 25-46.
[16]
Cerreia Vioglio, P.; Chierotti, M.R.; Gobetto, R. Pharmaceutical aspects of salt and cocrystal forms of apis and characterization challenges. Adv. Drug Deliv. Rev., 2017, 117, 86-110.
[17]
Savjani, J. Co-crystallization: An approach to improve the performance characteristics of active pharmaceutical ingredients. Asian J. Pharm., 2015, 9(3), 147.
[18]
Izutsu, K.; Koide, T.; Takata, N.; Ikeda, Y.; Ono, M.; Inoue, M.; Fukami, T.; Yonemochi, E. Characterization and quality control of pharmaceutical cocrystals. Chem. Pharm. Bull. (Tokyo), 2016, 64(10), 1421-1430.
[19]
Shan, N.; Zaworotko, M.J. The role of cocrystals in pharmaceutical science. Drug Discov. Today, 2008, 13(9-10), 440-446.
[20]
Thipparaboina, R.; Kumar, D.; Chavan, R.B.; Shastri, N.R. Multidrug co-crystals: towards the development of effective therapeutic hybrids. Drug Discov. Today, 2016, 21(3), 481-490.
[21]
Lorenzo, D.A.; Forrest, S.J.K.; Sparkes, H.A. Crystal engineering: Co-crystals of cinnamic acid derivatives with a pyridyl derivative co-crystallizer. Acta Crystallogr. Sect. B Struct. Sci. Cryst. Eng. Mater., 2016, 72(1), 87-95.
[22]
Aakeröy, C.B.; Salmon, D.J. Building co-crystals with molecular sense and supramolecular sensibility. CrystEngComm, 2005, 7(72), 439-448.
[23]
Aakeröy, C.B.; Beatty, A.M.; Helfrich, B.A. A high-yielding supramolecular reaction. J. Am. Chem. Soc., 2002, 124(48), 14425-14432.
[24]
Almarsson, Ö.; Zaworotko, M.J. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem. Commun., 2004, (17), 1889-1896.
[25]
Childs, S.L.; Zaworotko, M.J. The reemergence of cocrystals: the crystal clear writing is on the wall introduction to virtual special issue on pharmaceutical cocrystals. Cryst. Growth Des., 2009, 9(10), 4208-4211.
[26]
Moradiya, H.G.; Islam, M.T.; Halsey, S.; Maniruzzaman, M.; Chowdhry, B.Z.; Snowden, M.J.; Douroumis, D. Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing. CrystEngComm, 2014, 16(17), 3573-3583.
[27]
Eddleston, M.D.; Patel, B.; Day, G.M.; Jones, W. Cocrystallization by freeze-drying: Preparation of novel multicomponent crystal forms. Cryst. Growth Des., 2013, 13(10), 4599-4606.
[28]
Hasa, D.; Schneider, G.; Voinovich, D.; Jones, W. Cocrystal formation through mechanochemistry: From neat and liquid-assisted grinding to polymer-assisted grinding. Angew. Chemie. Int. Ed., 2015, 54(25), 7371-7375.
[29]
Braga, D.; Maini, L.; Grepioni, F. Mechanochemical preparation of co-crystals. Chem. Soc. Rev., 2013, 42(18), 7638-7648.
[30]
Braga, D.; Giaffreda, S.L.; Rubini, K.; Grepioni, F.; Chierotti, M.R.; Gobetto, R. Making crystals from crystals: Three solvent-free routes to the hydrogen bonded co-crystal between 1,1′-di-pyridyl-ferrocene and anthranilic acid. CrystEngComm, 2007, 9(1), 39-45.
[31]
James, S.L.; Adams, C.J.; Bolm, C.; Braga, D.; Collier, P.; Friić, T.; Grepioni, F.; Harris, K.D.M.; Hyett, G.; Jones, W.; Krebs, A.; Mack, J.; Maini, L.; Orpen, A.G.; Parkin, I.P.; Shearouse, W.C.; Steed, J.W.; Waddell, D.C. Mechanochemistry: Opportunities for new and cleaner synthesis. Chem. Soc. Rev., 2012, 41(1), 413-447.
[32]
Dubois, J.; Colaco, M.; Wouters, J. Mechanosynthesis, a method of choice in solid a method of choice in solid state synthesis state synthesis. Chim. Nouv, 2014, (1), 21-30.
[33]
Wieczorek-Ciurowa, K.; Gamrat, K. Some aspects of mechanochemical reactions. Mater. Sci., 2007, 25(1), 219-232.
[34]
Etter, M.C.; Zia-Ebrahimi, M.; Urbañczyk-Lipkowska, Z.; Panunto, T.W. Hydrogen bond directed cocrystallization and molecular recognition pro-perties of diarylureas. J. Am. Chem. Soc., 1990, 112(23), 8415-8426.
[35]
Do, J.L.; Friščić, T. Mechanochemistry: A force of synthesis. ACS Cent. Sci., 2017, 3(1), 13-19.
[36]
Karki, S.; Friščića, T.; Jones, W. Control and interconversion of cocrystal stoichiometry in grinding: Stepwise mechanism for the formation of a hydrogen-bonded cocrystal. CrystEngComm, 2009, 11(3), 470-481.
[37]
Chadwick, K.; Davey, R.; Cross, W. How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine. CrystEngComm, 2007, 9(9), 732-734.
[38]
Lien Nguyen, K.; Friščić, T.; Day, G.M.; Gladden, L.F.; Jones, W. Terahertz time-domain spectroscopy and the quantitative monitoring of mechano-chemical cocrystal formation. Nat. Mater., 2007, 6(3), 206-209.
[39]
Jayasankar, A.; Somwangthanaroj, A.; Shao, Z.J.; Rodríguez-Hornedo, N. Cocrystal formation during cogrinding and storage is mediated by amorphous phase. Pharm. Res., 2006, 23(10), 2381-2392.
[40]
Rehder, S.; Klukkert, M.; Löbmann, K.A.M.; Strachan, C.J.; Sakmann, A.; Gordon, K.; Rades, T.; Leopold, C.S. Investigation of the formation process of two piracetam cocrystals during grinding. Pharmaceutics, 2011, 3(4), 706-722.
[41]
Kaupp, G. Organic solid-state reactions with 100% yield. Top. Curr. Chem., 2005, 254, 95-183.
[42]
Friščić, T.; Childs, S.L.; Rizvi, S.A.A.; Jones, W. The role of solvent in mechanochemical and sonochemical cocrystal formation: A solubility-based approach for predicting cocrystallisation outcome. CrystEngComm, 2009, 11(3), 418-426.
[43]
Imai, Y.; Tajima, N.; Sato, T.; Kuroda, R. Molecular recognition in solid-state crystallization: Colored chiral adduct formations of 1,1′-bi-2-naphthol derivatives and benzoquinone with a third component. Chirality, 2002, 14(7), 604-609.
[44]
Patil, A.O.; Curtin, D.Y.; Paul, I.C. Interconversion by hydrogen transfer of unsymmetrically substituted quinhydrones in the solid State. Crystal structure of the 1:2 complex of 2,5-dimethylbenzoquinone with hydro-quinone. J. Am. Chem. Soc., 1984, 106(14), 4010-4015.
[45]
Chieng, N.; Hubert, M.; Saville, D.; Rades, T.; Aaltonen, J. Formation kinetics and stability of carbamazepine # nicotinamide cocrystals prepared by mechanical activation formation kinetics and stability of carbamazepinenicotinamide cocrystals prepared by mechanical activation XXXX. Cryst. Growth Des., 2009, 9(form I), 2377-2386.
[46]
Trask, A.V.; Samuel Motherwell, W.D.; Jones, W. Pharmaceutical cocry-stallization: Engineering a remedy for caffeine hydration. Cryst. Growth Des., 2005, 5(3), 1013-1021.
[47]
Heiden, S.; Tröbs, L.; Wenzel, K-J.; Emmerling, F. Mechanochemical synthesis and structural characterisation of a theophylline-benzoic acid cocrystal (1 : 1). CrystEngComm, 2012, 14(16), 5128.
[48]
Friščić, T.; Trask, A.V.; Jones, W.; Motherwell, W.D.S. Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. Angew. Chem. Int. Ed., 2006, 45(45), 7546-7550.
[49]
Otsuka, Y.; Ito, A.; Takeuchi, M.; Tanaka, H. Dry mechanochemical synthesis of caffeine/oxalic acid cocrystals and their evaluation by powder X-ray diffraction and chemometrics. J. Pharm. Sci., 2017, 106(12), 3458-3464.
[50]
Basavoju, S.; Boström, D.; Velaga, S.P. Indomethacin-saccharin cocrystal: Design, Synthesis and preliminary pharmaceutical characterization. Pharm. Res., 2008, 25(3), 530-541.
[51]
Trask, A.V.; Shan, N.; Motherwell, W.D.S.; Jones, W.; Feng, S.; Tan, R.B.H.; Carpenter, K.J. Selective polymorph transformation via solvent-drop grinding. Chem. Commun., 2005, (7), 880-882.
[52]
Ross, S.A.; Lamprou, D.A.; Douroumis, D. Engineering and manufacturing of pharmaceutical co-crystals: A review of solvent-free manufacturing technologies. Chem. Commun., 2016, 52(57), 8772-8786.
[53]
Shan, N.; Toda, F.; Jones, W. Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics. Chem. Commun., 2002, 2(20), 2372-2373.
[54]
Berry, D.J.; Seaton, C.C.; Clegg, W.; Harrington, R.W.; Coles, S.J.; Horton, P.N.; Hursthouse, M.B.; Storey, R.; Jones, W.; Friščić, T.; Blagden, N. Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients. Cryst. Growth Des., 2008, 8(5), 1697-1712.
[55]
Karki, S.; Fabian, L.; Friscic, T.; Jones, W. Powder X-ray diffraction emerging method characterize organic solids. Org. Lett., 2007, 9(16), 3133-3136.
[56]
Madusanka, N.; Mark, D. Crystal engineering polymorphs, hydrates and solvates of a co-crystal of caffeine with anthranilic acid crystal engineering., 2014, 2012, 72-80.
[57]
Weyna, D.R.; Shattock, T.; Vishweshwar, P.; Zaworotko, M.J. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: Mechanochemistry vs slow evaporation from solution. Cryst. Growth Des., 2009, 9(2), 1106-1123.
[58]
Trask, A.V.; Motherwell, W.D.S.; Jones, W. Solvent-drop grinding: Green polymorph control of cocrystallisation. Chem. Commun., 2004, (7), 890.
[59]
Trask, A.V.; Van De Streek, J.; Motherwell, W.D.S.; Jones, W. Achieving polymorphic and stoichiometric diversity in cocrystal formation: importance of solid-state grinding, powder x-ray structure determination, and seeding. Cryst. Growth Des., 2005, 5(6), 2233-2241.
[60]
Jones, W.; Eddleston, M.D. Introductory lecture: Mechanochemistry, a versatile synthesis strategy for new materials. Faraday Discuss., 2014, 170, 9-34.
[61]
Jung, S.; Choi, I.; Kim, I. Liquid-assisted grinding to prepare a cocrystal of adefovir dipivoxil thermodynamically less stable than its neat phase. Crystals, 2015, 5(4), 583-591.
[62]
Reichert, W.M.; Holbrey, J.D.; Vigour, K.B.; Morgan, T.D.; Broker, G.A.; Rogers, R.D. Approaches to crystallization from ionic liquids: complex solvents-complex results, or, a strategy for controlled formation of new supramolecular architectures? Chem. Commun., 2006, (46), 4767-4779.
[63]
Rogers, R.D. Cocrystal Formation by Ionic Liquid-Assisted Grinding: Case Study with Cocrystals of Caffeine. CrystEngComm, 2018, 20, 1-5.
[64]
Tan, D.; Loots, L.; Friščić, T. Towards medicinal mechanochemistry: evolution of milling from pharmaceutical solid form screening to the synthesis of active pharmaceutical ingredients (APIs). Chem. Commun., 2016, 52(50), 7760-7781.
[65]
Korde, S.; Pagire, S.; Pan, H.; Seaton, C.; Kelly, A.; Chen, Y.; Wang, Q.; Coates, P.; Paradkar, A. Continuous manufacturing of cocrystals using solid state shear milling technology. Cryst. Growth Des., 2018, 18(4), 2297-2304.
[66]
Liu, X.; Lu, M.; Guo, Z.; Huang, L.; Feng, X.; Wu, C. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm. Res., 2012, 29(3), 806-817.
[67]
Crawford, D.E. Extrusion - Back to the future: Using an established technique to reform automated chemical synthesis. Beilstein J. Org. Chem., 2017, 13, 65-75.
[68]
Paradkar, A.; Dhumal, R.S.; Kelly, A.L.; York, P.; Coates, P.D. Cocrystalization and simultaneous agglomeration using hot melt extrusion. Pharm. Res., 2010, 27(12), 2725-2733.
[69]
Crowley, M.M.; Zhang, F.; Repka, M.A.; Thumma, S.; Upadhye, S.B.; Battu, S.K.; McGinity, J.W.; Martin, C. Pharmaceutical applications of hot-melt extrusion: Part I. Drug Dev. Ind. Pharm., 2007, 33(9), 909-926.
[70]
Douroumis, D. Hot-Melt Extrusion: Pharmaceutical Applications; John Wiley & Sons: UK, 2012.
[71]
Follonier, N.; Doelker, E.; Cole, E.T. Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs. Drug Development and Industrial Pharmacy., 1994, 20(8), 1323-1339.
[72]
Crowley, M.M.; Fredersdorf, A.; Schroeder, B.; Kucera, S.; Prodduturi, S.; Repka, M.A.; McGinity, J.W. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur. J. Pharm. Sci., 2004, 22(5), 409-418.
[73]
Breitenbach, J. Melt extrusion: From process to drug delivery technology. Eur. J. Pharm. Biopharm., 2002, 54(2), 107-117.
[74]
Nikitine, C.; Rodier, E.; Sauceau, M.; Fages, J. Residence time distribution of a pharmaceutical grade polymer melt in a single screw extrusion process. Chem. Eng. Res. Des., 2009, 87(6), 809-816.
[75]
Moradiya, H.; Islam, M.T.; Woollam, G.R.; Slipper, I.J.; Halsey, S.; Snowden, M.J.; Douroumis, D. Continuous cocrystallization for dissolution rate optimization of a poorly water-soluble drug. Cryst. Growth Des., 2014, 14(1), 189-198.
[76]
Boksa, K.; Otte, A.; Pinal, R. Matrix-Assisted Cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion. J. Pharm. Sci., 2014, 103(9), 2904-2910.
[77]
Duarte, Í.; Andrade, R.; Pinto, J.F.; Temtem, M. Green production of cocrystals using a new solvent-free approach by spray congealing. Int. J. Pharm., 2016, 506(1-2), 68-78.
[78]
Douroumis, D.; Ross, S.A.; Nokhodchi, A. Advanced methodologies for cocrystal synthesis. Adv. Drug Deliv. Rev., 2017, 117, 178-195.
[79]
Pagire, S.; Korde, S.; Ambardekar, R.; Deshmukh, S.; Dash, R.C.; Dhumal, R.; Paradkar, A. Microwave assisted synthesis of caffeine/maleic acid co-crystals: the role of the dielectric and physicochemical properties of the solvent. CrystEngComm, 2013, 15(18), 3705-3710.
[80]
Titapiwatanakun, V.; Basit, A.W.; Gaisford, S. A new method for producing pharmaceutical co-crystals: Laser irradiation of powder blends. Cryst. Growth Des., 2016, 16(6), 3307-3312.
[81]
Boterashvili, M.; Lahav, M.; Shankar, S.; Facchetti, A.; Boom, M. E.; Van Der, On-surface solvent-free crystal-to-co-crystal conversion by noncovalent interactions. 2014, 136(34), 11926-11929.
[82]
Am Ende, D.J.; Anderson, S.R.; Salan, J.S. Development and scale-up of cocrystals using resonant acoustic mixing. Org. Process Res. Dev., 2014, 18(2), 331-341.
[83]
Jerry, S.; Anderson, S.R.; Am Ende, D. A method to produce and scale-up cocrystals and salts via resonant acoustic mixing. Eur. Pat. Appl., 2014, 2845852A1.
[84]
Nagapudi, K.; Umanzor, E.Y.; Masui, C. High-throughput screening and scale-up of cocrystals using resonant acoustic mixing. Int. J. Pharm., 2017, 521(1-2), 337-345.
